The diagnostic utility of procalcitonin, interleukin-6 and interleukin-8, and hyaluronic acid in the Norwegian consensus definition for early-onset neonatal sepsis (EONS) [Retraction]
Nakstad B. The diagnostic utility of procalcitonin, interleukin- 6 and interleukin-8, and hyaluronic acid in the Norwegian consensus definition for early-onset neonatal sepsis (EONS). Infection and Drug Resistance. 2018:11;359–368.
At the request of the author, the Editor-in-Chief and Publisher of the Infection and Drug Resistance wish to retract the published article. On review of a previous draft and the published article the author noticed both versions had identical correlation, r and significance values, p in the results section “Overall response in soluble biomarkers”. The raw data sets used in both versions were not identical and it was not possible for both data sets to produce the same correlation and significance values. A recalculation of the raw data set used for the published version showed no correlation in neonatal plasma between PCT and IL-8 and PCT and IL-6 which differed considerably to the positive correlation result presented in the published article. Additionally, some of the patients reported with positive blood culture were older than 72 h at onset of symptoms and should not have been included as early-onset neonatal sepsis (EONS) patients. Therefore, the findings and recommendations presented in the article are not supported.
The author wishes to apologize for the error.
This retraction relates to this paper
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF]